Marcel Schulz

@themarcelschulz.bsky.social

Director of Institute for Computational Genomic Medicine at Goethe University Frankfurt https://cgm.uni-frankfurt.de/

If you don't like a paper, it is obviously totally fine to point out the issues. But please do NOT make egregious and unpleasant comments about the first author's qualifications. A first author who is usually a trainee. Beyond inappropriate and unprofessional.

An encyclopedia of enhancer-gene regulatory interactions — online today! nature.com/articles/s4158… Now with an improved model, expanded maps across 1400+ biosamples, larger validation CRISPR datasets, and guidance on applying the model 1/

nature.com

Andreas Gschwind@argschwind.bsky.social · last mo.

Thrilled to share that our ENCODE enhancer–gene mapping paper is now out in Nature! An encyclopedia of human enhancer–gene regulatory interactions: www.nature.com/articles/s41... Thread 👇 1/

it is worrying to see how easy it is to make your way into a LLM. In these papers, there are obvious clues that the results are fake. What about fake papers where there are fewer obvious clues? How can these be detected.

Chris Stokel-Walker@stokel.bsky.social · 5mo ago

🚨 For nearly two years - and even now, depending on the day and model - AI models could tell you all about bixonimania, a totally made-up disease in a paper funded by “the Professor Sideshow Bob Foundation". My @nature.com story on AI's fallibility in medicine www.nature.com/articles/d41...

Epstein-Barr Virus #EBV was linked to #MultipleSclerosis - now a plausible cause has been found, misidentification by longterm memory T-cells that pick on the wrong protein, ANO2, instead of the EBV-antigen. Massive inflection towards the elimination of MS!!! 🧪🧠Cell www.cell.com/cell/fulltex...

Anoctamin-2-specific T cells link Epstein-Barr virus to multiple sclerosis

Researchers identified anoctamin-2 (ANO2) as a frequent autoimmune target in multiple sclerosis, with T cell responses against ANO2 occurring in over half of patients. These ANO2-specific T cells shar...

cell.com

Very excited that our most significant work, a collaboration w/ Dr. Can Cenik at UT Austin on translational gene regulation, was finally published in Nature Biotechnology in a dual set of studies: Paper 1 -- an AI model trained to predict translation rates from mRNA sequences: rdcu.be/exN1l

Predicting the translation efficiency of messenger RNA in mammalian cells

Nature Biotechnology - A deep convolutional neural network model predicts the influence of the full-length mRNA sequence on translation efficiency.

url.de.m.mimecastprotect.com